People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nanomedex Pharmaceuticals Inc | — | Pharmaceuticals | Pre-Seed | $500K | $23.7M | 2009 |
Jeffrey C. Girard at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey C. Girard on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth U Johnson | 1 | 5 |
| Mark A. Nottoli | 1 | 1 |
| Nikolaus Gravenstein | 1 | 1 |
| Timothy E. Morey | 1 | 1 |
| David L. Cooper | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.